Phase 1 × Has results × Carcinoma, Hepatocellular × Clear all A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases
Phase 1 Completed
55 enrolled 30 charts
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Phase 1 Completed
184 enrolled 20 charts
Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC
Phase 1 Completed
10 enrolled 14 charts
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Phase 1 Completed
58 enrolled 17 charts
A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma
Phase 1 Completed
104 enrolled 41 charts
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Phase 1 Completed
128 enrolled 27 charts
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Phase 1 Completed
174 enrolled 68 charts
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
Phase 1 Completed
27 enrolled 13 charts
A Study of LY3435151 in Participants With Solid Tumors
Phase 1 Terminated
2 enrolled 8 charts
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Phase 1 Completed
22 enrolled 15 charts
TARDOX
Phase 1 Completed
10 enrolled 13 charts
MEDI-573-1028
Phase 1 Completed
6 enrolled 15 charts
A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer
Phase 1 Completed
8 enrolled 16 charts
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy
Phase 1 Terminated
26 enrolled 44 charts
A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Phase 1 Completed
58 enrolled 13 charts
MIAMINK
Phase 1 Completed
18 enrolled 5 charts
Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma
Phase 1 Completed
30 enrolled 12 charts
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
Phase 1 Terminated
12 enrolled 7 charts
Asian Phase I Study Of PF-03446962
Phase 1 Completed
36 enrolled 24 charts